Net Loss Per Share (Details 1) - shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Net Loss Per Share (Tables) | ||
| Warrants outstanding | 45,577 | 70,361 |
| Stock options outstanding | 538,713 | 515,847 |
| RSAs outstanding | 188,588 | 0 |
| RSUs outstanding | 0 | 243,800 |
| Series A convertible preferred stock to common shares | 0 | 79,304 |
| Series B convertible preferred stock to common shares | 0 | 272,084 |
| Total | 772,878 | 1,181,396 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The increase or decrease in number of shares reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding, including vested options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|